Clinical Effectiveness of the Comprehensive, High-Dose Aphasia Treatment Program for People With Poststroke Aphasia.

Saved in:
Bibliographic Details
Title: Clinical Effectiveness of the Comprehensive, High-Dose Aphasia Treatment Program for People With Poststroke Aphasia.
Authors: Dignam, Jade1,2 j.dignam@uq.edu.au, Burfein, Penni1,2,3, Campbell, Jessica1,2, Coleman, Adele1,2, Fraser, Caitlin2,4, Halpin, Jessica2,4, Hill, Annie1,2,5, O'Brien, Kate1,2, O'Neill, Emma2,4, Roxas, Katherine2,4, Short, Kylie2,4, Shrubsole, Kirstine1,2, Stuckey, Renee2,4, Wedley, Hannah1,2, Copland, David A.1,2
Source: Journal of Speech, Language & Hearing Research. Dec2025, Vol. 68 Issue 12, p5938-5949. 12p.
Subject Terms: *Human services programs, *Experimental design, *Longitudinal method, *Pre-tests & post-tests, *Quality of life, *Communication, Research funding, Rehabilitation of aphasic persons, Evaluation of human services programs, Pilot projects, Clinical trials, Treatment effectiveness, Descriptive statistics, Rehabilitation centers, Stroke, Stroke patients, Psychosocial factors, Regression analysis, Disease complications
Geographic Terms: Australia
Abstract: Purpose: Intensive comprehensive aphasia programs (ICAPs) are a novel service delivery model incorporating best practice principles in aphasia rehabilitation. Despite increased evidence, adoption of this model into health care services remains limited. This study evaluated the feasibility and effectiveness of the comprehensive, high-dose aphasia treatment (CHAT) program, a modified-ICAP, when implemented by a public rehabilitation facility in Brisbane, Australia. Method: A nonrandomized, Type II hybrid clinical implementation and effectiveness study design was employed. The CHAT program includes 50 hr of goal-directed aphasia rehabilitation, delivered over 8 weeks. Sixty-seven adults with poststroke aphasia consented to the study. Feasibility was evaluated using service statistics (i.e., referrals, adherence, dose) and analyzed using descriptive statistics. Effectiveness evaluated changes in participants' language impairment, communication activity and participation, and quality of life at posttherapy and 3-month follow-up. Group-level data were analyzed using linear mixed models and Cohen's d effect sizes. Minimal detectable change (MDC90) was used to determine changes at the individual participant level. Results: Fourteen cohorts of CHAT were delivered from February 2021 to December 2023. Sixty-five participants completed CHAT, with an average dose of 46.6 hr of therapy. Group-level analyses revealed significant improvements in participants' language impairment, communication activity and participation, and quality of life (p < .05) at posttherapy and 3-month follow-up. Most participants (89%) demonstrated significant improvements on at least one outcome measure. Conclusions: The CHAT program was feasibly delivered within a public, health care context and resulted in positive and enduring changes in participants' language impairment, communication function, and quality of life. Supplemental Material: https://doi.org/10.23641/asha.30522767 [ABSTRACT FROM AUTHOR]
Copyright of Journal of Speech, Language & Hearing Research is the property of American Speech-Language-Hearing Association and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Education Research Complete
Be the first to leave a comment!
You must be logged in first